These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17067190)

  • 21. Artificial intelligence framework for simulating clinical decision-making: a Markov decision process approach.
    Bennett CC; Hauser K
    Artif Intell Med; 2013 Jan; 57(1):9-19. PubMed ID: 23287490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of different uncertainty techniques in urban stormwater quantity and quality modelling.
    Dotto CB; Mannina G; Kleidorfer M; Vezzaro L; Henrichs M; McCarthy DT; Freni G; Rauch W; Deletic A
    Water Res; 2012 May; 46(8):2545-58. PubMed ID: 22402270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
    Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
    Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving early cycle economic evaluation of diagnostic technologies.
    Steuten LM; Ramsey SD
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):491-8. PubMed ID: 24766321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model performance evaluation (validation and calibration) in model-based studies of therapeutic interventions for cardiovascular diseases : a review and suggested reporting framework.
    Haji Ali Afzali H; Gray J; Karnon J
    Appl Health Econ Health Policy; 2013 Apr; 11(2):85-93. PubMed ID: 23456647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models.
    Hollman C; Paulden M; Pechlivanoglou P; McCabe C
    Pharmacoeconomics; 2017 Aug; 35(8):817-830. PubMed ID: 28488257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review and classification of approaches for dealing with uncertainty in multi-criteria decision analysis for healthcare decisions.
    Broekhuizen H; Groothuis-Oudshoorn CG; van Til JA; Hummel JM; IJzerman MJ
    Pharmacoeconomics; 2015 May; 33(5):445-55. PubMed ID: 25630758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice.
    O'Mahony JF; Newall AT; van Rosmalen J
    Pharmacoeconomics; 2015 Dec; 33(12):1255-68. PubMed ID: 26105525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.
    Sculpher M; Fenwick E; Claxton K
    Pharmacoeconomics; 2000 May; 17(5):461-77. PubMed ID: 10977388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels.
    van Velden ME; Severens JL; Novak A
    Pharmacoeconomics; 2005; 23(11):1075-82. PubMed ID: 16277545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision-analytical modelling in health-care economic evaluations.
    Sun X; Faunce T
    Eur J Health Econ; 2008 Nov; 9(4):313-23. PubMed ID: 17943332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling.
    Williams C; Lewsey JD; Mackay DF; Briggs AH
    Med Decis Making; 2017 May; 37(4):427-439. PubMed ID: 27698003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. epidemix-An interactive multi-model application for teaching and visualizing infectious disease transmission.
    Muellner U; Fournié G; Muellner P; Ahlstrom C; Pfeiffer DU
    Epidemics; 2018 Jun; 23():49-54. PubMed ID: 29273280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic assessment of decision-analytic models for chronic myeloid leukemia.
    Rochau U; Schwarzer R; Jahn B; Sroczynski G; Kluibenschaedl M; Wolf D; Radich J; Brixner D; Gastl G; Siebert U
    Appl Health Econ Health Policy; 2014 Apr; 12(2):103-15. PubMed ID: 24385259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health system re-engineering: a CPRS economic decision model.
    Diehl M
    Proc Annu Symp Comput Appl Med Care; 1995; ():688-92. PubMed ID: 8563375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation.
    Dodd PJ; Pennington JJ; Bronner Murrison L; Dowdy DW
    Med Decis Making; 2018 Nov; 38(8):930-941. PubMed ID: 30403578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review of the use and value of computer simulation modelling in population health and health care delivery.
    Fone D; Hollinghurst S; Temple M; Round A; Lester N; Weightman A; Roberts K; Coyle E; Bevan G; Palmer S
    J Public Health Med; 2003 Dec; 25(4):325-35. PubMed ID: 14747592
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.